Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01225991 · ClinicalTrials.gov registry record · Phase 4

Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis

A Phase 4 study of Rheumatoid Arthritis, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 4
Development phase
18
Enrollment target
1
Study location

NCT01225991: Completed Phase 4 study of Rheumatoid Arthritis, sponsored by University of California, Los Angeles.

NCT01225991 is a Phase 4 study of Rheumatoid Arthritis that has completed, run by University of California, Los Angeles. The registered enrollment target is 18 participants, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01225991, a Phase 4 study of Rheumatoid Arthritis, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 4
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the effects of milnacipran for the treatment of pain in rheumatoid arthritis in older adults.

Primary Outcome

The Pain Rating Index ranked values associated with adjectives depicting the severity of pain from the McGill Pain Questionnaire (MPQ). The assessment is comprised of 15 adjectives, each of which is scored on a scale ranging from 0 (none) to 3 (severe) and summed to arrive at a score ranging from 0 (no pain) to 45 (worst possible pain), to measure the extent of pain/tenderness and swelling. The Pain Rating Index final scores were averaged to indicate an overall report of joint pain and stiffness

Conditions Studied

Rheumatoid Arthritis

Interventions

  • DRUG Milnacipran

Study Locations (1)

California

  • UCLA Semel Institute - Los Angeles

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2010-11
Est. Completion 2013-06
Phase Phase 4
University of California, Los Angeles

897 total trials

What the finished NCT01225991 record still lists

NCT01225991 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Milnacipran is the first listed.

NCT01225991 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01225991 about?

NCT01225991 is a clinical study titled "Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis". The purpose of this study is to examine the effects of milnacipran for the treatment of pain in rheumatoid arthritis in older adults.

What is the current status of trial NCT01225991?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2010-11. Estimated completion is 2013-06.

What conditions does trial NCT01225991 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT01225991?

The interventions under investigation include: Milnacipran (DRUG).

Who is sponsoring clinical trial NCT01225991?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01225991 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01225991's enrollment target sits among peer trials

18 182nd of 197 higher than 14 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01225991, the US trial registry maintained by the National Library of Medicine. NCT01225991 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.